Related Experiment Video
Updated: Jul 4, 2026
15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
Detection of pancreatic cancer using antibody microarray-based serum protein profiling
Johan Ingvarsson1, Christer Wingren, Anders Carlsson
1Department of Immunotechnology, Lund University, Lund, Sweden.
Proteomics
|June 6, 2008
Summary
Oncoproteomics uses antibody microarrays to find protein signatures in pancreatic cancer patients. This research identified distinct protein signatures differentiating cancer patients from healthy individuals and predicting prognosis.
Area of Science:
- Biochemistry
- Proteomics
- Oncology
Background:
- Oncoproteomics aims to identify protein signatures linked to specific malignancies.
- Pancreatic cancer is a significant health concern requiring improved diagnostic and prognostic tools.
Purpose of the Study:
- To classify sera from pancreatic adenocarcinoma patients versus healthy subjects using a recombinant scFv antibody microarray.
- To identify protein signatures associated with pancreatic cancer and patient prognosis.
Main Methods:
- Analysis of nonfractionated, directly labeled, whole human serum proteomes.
- Utilized a recombinant single-chain variable fragment (scFv) antibody microarray platform.
- Statistical analysis to identify discriminating protein analytes.
Main Results:
- A protein signature of 19 nonredundant analytes was identified, distinguishing pancreatic cancer patients from healthy subjects.
- A separate signature of 21 protein analytes was associated with pancreatic cancer patients having a life expectancy of less than 12 months.
Conclusions:
- Antibody microarray analysis of complex proteomes is a valuable tool for defining disease-associated protein signatures.
- The identified signatures show potential for diagnosing pancreatic cancer and predicting patient outcomes.
